Skip to main content
Clinical Trials/NCT01306851
NCT01306851
Unknown
Phase 4

Multicenter, Randomized, Controlled, Single Blinded, Phase IV Study Comparing 2 Parallel Groups in the Evaluation of the Prevention of Anastomotic Leaks in GI High Risk Anastomosis, With or Without the Application of Fibrin Glue in the Anastomotic Line

Hospital General Universitario Gregorio Marañon1 site in 1 country200 target enrollmentStarted: June 2007Last updated:
InterventionsFibrin glue

Overview

Phase
Phase 4
Sponsor
Hospital General Universitario Gregorio Marañon
Enrollment
200
Locations
1
Primary Endpoint
Occurence of anastomotic leak

Overview

Brief Summary

The anastomotic leak is one of the most feared complications in abdominal surgery. Certain control methods have been described but the incidence of that complication remains high and is the first cause of mortality in operations where gut anastomosis are performed.

With the aim to prove that the use of fibrin glue in the gut anastomosis can improve gut cicatrization, the investigators started the recruitment of patients to that clinical trial in 2007 with the study hypothesis that patients with a gut anastomosis where fibrin glue was used, had less anastomotic leaks than that where the fibrin glue was not used.

The investigators have calculated the number of patients necessaries to have statistical significant differences in 200 patients with a rate anastomotic leak expected to be higher than 10%.

The study include all the patients that usually arrive to our surgery department and that are expected to have a high risk gut anastomosis: rectal anastomosis, GI anastomosis in the obese patient, small bowel anastomosis in the obstructed one and esophageal anastomosis.

The study is randomized, simple blind where the patient does not know if they are in the fibrin glue group or not, and prospectively analyzed. All the clinical and laboratory or radiographic finds relative to the occurrence of an anastomotic leak are recorded.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing GI surgery where a high risk anastomosis is preview to be done

Exclusion Criteria

  • Haemodynamic instability
  • Advanced oncologic disease
  • Proteins below 4 gr/ml

Arms & Interventions

Fibrin glue

Active Comparator

Intervention: Fibrin glue (Drug)

Outcomes

Primary Outcomes

Occurence of anastomotic leak

Time Frame: 6 months

The occurence of anastomotic leak in the 6 months after the surgery is the most important factor to determine if fibrin glue is helpful in the prevention of that complicacion.

Secondary Outcomes

  • Evidence of infectious collections in the anastomotic area(3 months)

Investigators

Sponsor
Hospital General Universitario Gregorio Marañon
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials